Actively Recruiting
Global Prospective Observational Study to Collect Data from Adults with Primary Sclerosing Cholangitis WIND-PSC to Support Drug Development
Led by PSC Partners Seeking a Cure · Updated on 2026-10-13
2000
Participants Needed
18
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a global, multi-center observational study to collect detailed clinical information from adult patients diagnosed with large duct Primary Sclerosing Cholangitis PSC. The goal is to develop a real-world data comparator group to support and improve the design and execution of future interventional clinical trials for PSC. This study aims to provide valuable external control data to better understand this condition over time. Participants will be observed longitudinally, with prospective collection of clinical data including liver-related outcomes, safety events, hepatobiliary cancers, key biomarkers, imaging results, PSC-related symptoms, patient-reported health outcomes, and medication usage. Data will be collected regularly over five years from enrollment to build a comprehensive dataset for research. During the study, participants will undergo assessments quarterly for five years, which include clinical evaluations, biomarker testing, imaging, and questionnaires about their experiences and symptoms. Researchers will monitor disease progression, safety, and other health changes. The study focuses on gathering information without administering any treatments, and participants will be followed closely to support future PSC drug development.
CONDITIONS
Brief Title
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Research Team
S
Stephen Rossi, PharmD
Z
Zuha Jeddy, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here